Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products

Abstract

Plasma fractionation processes used in the manufacture of albumin, immunoglobulins, factor-VIII concentrate, factor-IX concentrates, fibrinogen and thrombin all contain steps which may be capable of removing causative agents of human TSEs.